Group leader Ton Schumacher was elected for his vast contributions to characterizing antitumor immunity, defining how immune cells identify and target tumor-specific neoantigens, and for pioneering technologies that allow for high-throughput analysis of immune cell reactivity to cancer neoantigens, which have effectively transformed clinical approaches to precision immunotherapeutic treatment strategies.
On March 29, the American Association for Cancer Research (AACR) announced its newly elected class of 25 Fellows of the AACR Academy. The mission of the AACR Academy is to recognize and honor distinguished scientists whose scientific contributions have propelled significant innovation and progress against cancer. Fellows of the AACR Academy serve as a global brain trust of top contributors to cancer science and medicine who help advance the mission of the AACR to prevent and cure all cancers through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.